Total Payments
$22,098
2024 Payments
$3,005
Companies
73
Transactions
1,605
Medicare Patients
4,674
Medicare Billing
$618,113
Payment Breakdown by Category
Food & Beverage$21,889 (99.1%)
Education$208.53 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,889 | 1,592 | 99.1% |
| Education | $208.53 | 13 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,048 | 141 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,869 | 110 | $0 (2024) |
| Lilly USA, LLC | $1,609 | 164 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,485 | 117 | $0 (2024) |
| Novo Nordisk Inc | $1,381 | 114 | $0 (2024) |
| PFIZER INC. | $1,309 | 94 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $906.21 | 65 | $0 (2024) |
| Amgen Inc. | $787.82 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $776.75 | 57 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $717.31 | 62 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,005 | 175 | ABBVIE INC. ($548.61) |
| 2023 | $2,982 | 186 | AbbVie Inc. ($691.35) |
| 2022 | $3,203 | 206 | ABBVIE INC. ($415.87) |
| 2021 | $2,253 | 174 | AbbVie Inc. ($305.53) |
| 2020 | $2,154 | 155 | AstraZeneca Pharmaceuticals LP ($403.56) |
| 2019 | $2,358 | 197 | AstraZeneca Pharmaceuticals LP ($243.33) |
| 2018 | $3,009 | 261 | AstraZeneca Pharmaceuticals LP ($321.65) |
| 2017 | $3,133 | 251 | AstraZeneca Pharmaceuticals LP ($304.31) |
All Payment Transactions
1,605 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes Care | ||||||
| 11/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: VACCINE | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: PAIN | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Biological | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,102 | 1,835 | $348,994 | $134,371 |
| 2022 | 24 | 1,225 | 2,007 | $407,524 | $157,527 |
| 2021 | 18 | 1,149 | 1,899 | $415,580 | $160,472 |
| 2020 | 20 | 1,198 | 1,946 | $434,488 | $165,744 |
Total Patients
4,674
Total Services
7,687
Medicare Billing
$618,113
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 611 | $125,255 | $44,873 | 35.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 124 | 244 | $49,776 | $21,788 | 43.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 151 | 167 | $34,736 | $14,377 | 41.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 80 | $31,440 | $10,365 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 162 | $22,518 | $9,333 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $14,430 | $8,036 | 55.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 42 | $22,218 | $6,798 | 30.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 23 | $10,189 | $4,846 | 47.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $6,600 | $3,168 | 48.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $5,830 | $3,102 | 53.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 99 | 233 | $8,155 | $2,204 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,985 | $1,172 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $4,170 | $1,114 | 26.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 19 | 35 | $2,765 | $1,037 | 37.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $987.00 | $607.53 | 61.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 16 | $1,648 | $595.35 | 36.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 13 | 13 | $845.00 | $412.36 | 48.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $312.00 | $305.76 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 20 | $960.00 | $182.41 | 19.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 25 | $175.00 | $55.00 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 203 | 492 | $100,860 | $37,898 | 37.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 165 | 387 | $78,948 | $30,999 | 39.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 91 | $48,139 | $15,570 | 32.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 129 | 150 | $31,200 | $11,986 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $17,538 | $9,864 | 56.2% |
About Dr. Kevin Sponseller, MD
Dr. Kevin Sponseller, MD is a Personal Emergency Response Attendant healthcare provider based in Hartsville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1851709554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Sponseller, MD has received a total of $22,098 in payments from pharmaceutical and medical device companies, with $3,005 received in 2024. These payments were reported across 1,605 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($21,889).
As a Medicare-enrolled provider, Sponseller has provided services to 4,674 Medicare beneficiaries, totaling 7,687 services with total Medicare billing of $618,113. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Personal Emergency Response Attendant
- Other Specialties Family Medicine, Student in an Organized Health Care Education/Training Program
- Location Hartsville, SC
- Active Since 07/25/2014
- Last Updated 08/23/2023
- Taxonomy Code 146D00000X
- Entity Type Individual
- NPI Number 1851709554
Products in Payments
- VRAYLAR (Drug) $1,482
- FARXIGA (Drug) $1,279
- JARDIANCE (Drug) $1,021
- XIFAXAN (Drug) $692.81
- Ozempic (Drug) $622.50
- Linzess (Drug) $583.47
- TRULICITY (Drug) $521.43
- ELIQUIS (Drug) $507.80
- TRADJENTA (Drug) $507.56
- TRELEGY ELLIPTA (Drug) $486.32
- LINZESS (Drug) $455.07
- UBRELVY (Drug) $440.22
- NURTEC ODT (Drug) $378.45
- MOUNJARO (Drug) $374.28
- EMGALITY (Drug) $351.16
- Kerendia (Drug) $350.08
- TRINTELLIX (Drug) $338.87
- CHANTIX (Drug) $310.77
- ENTRESTO (Drug) $298.30
- CAPLYTA (Drug) $288.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.